Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
FENBENDAZOLE
Intervet Ireland Limited
QP52AC13
FENBENDAZOLE
18.75 %w/w
Oral Paste
LM-Licensed Merchant
Equine - Food
Fenbendazole
Endoparasiticide
Authorised
1999-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur Equine Oral Paste 18.75 %w/w 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Oral paste. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses and other equine species 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of immature and mature stages of nematodes of the gastro-intestinal tract of horses and other equine species. Sensitive endoparasites include adult and immature stages of: Large and small strongyles Ascarids, _Oxyuris equi_ _Strongyloides _spp. _Dictyocaulus arnfeldi_ Panacur is effective for the treatment of immature and migrating strongyle infections in equines. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredient. Each g paste contains: ACTIVE SUBSTANCE Fenbendazole 187.5 mg EXCIPIENTS Methyl Parahydroxybenzoate 1.7 mg Propyl Parahydroxybenzoate 0.16 mg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 22/07/2011_ _CRN 7010158_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device. Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly Pročitajte cijeli dokument